NYSE undervalued ranking
Ranked by the Rule of 40 strategy. Lower valuation ranks higher. · Healthcare
Data as of: 2026-10-30 · end-of-day, not real-time
Information & education only — not investment advice or a guarantee of returns.
Best Undervalued NYSE Stocks (2026) →
Best Balanced NYSE Stocks (2026) →
💡 Preset screens
Rule of 40 — Growing software where growth + margin ≥ 40
Built from: Rule of 40 · EV/Sales · FCF Yield
Details →14 stocks · 2 value-trap stocks hidden
Return periodtrading days (holidays excluded)
Sort
1Eli Lilly and CompanyLLY NYSE · HealthcareP/E47.695.2①
Mkt Cap
$1.26T
P/E
47.6
P/B
47.8
1M
+24.0%
2Bristol-Myers Squibb CompanyBMY NYSE · HealthcareP/E13.873.3①
Mkt Cap
$127.7B
P/E
13.8
P/B
6.9
1M
+2.2%
3Merck & Company Inc.MRK NYSE · HealthcareP/E118.768.6①
Mkt Cap
$368.9B
P/E
118.7
P/B
8.8
1M
+3.6%
4Pfizer Inc.PFE NYSE · HealthcareP/E40.258.4①
Mkt Cap
$174.0B
P/E
40.2
P/B
2.0
1M
+9.8%
5Medtronic plc.MDT NYSE · HealthcareP/E23.754.5
Mkt Cap
$123.5B
P/E
23.7
P/B
2.5
1M
+11.8%
6AbbVie Inc.ABBV NYSE · HealthcareP/E83.352.9①
Mkt Cap
$521.1B
P/E
83.3
P/B
–
1M
+12.9%
7Novartis AGNVS NYSE · HealthcareP/E30.751.9
Mkt Cap
$303.7B
P/E
30.7
P/B
8.2
1M
+14.0%
8CVS Health CorporationCVS NYSE · HealthcareP/E23.851.7
Mkt Cap
$115.4B
P/E
23.8
P/B
1.4
1M
+5.1%
9McKesson CorporationMCK NYSE · HealthcareP/E26.748.9①
Mkt Cap
$116.0B
P/E
26.7
P/B
–
1M
+10.2%
10UnitedHealth Group IncorporatedUNH NYSE · HealthcareP/E23.246.0
Mkt Cap
$365.3B
P/E
23.2
P/B
3.5
1M
+9.4%
11Johnson & JohnsonJNJ NYSE · HealthcareP/E41.542.9
Mkt Cap
$657.7B
P/E
41.5
P/B
8.1
1M
+6.7%
12Danaher CorporationDHR NYSE · HealthcareP/E38.440.5
Mkt Cap
$163.3B
P/E
38.4
P/B
3.0
1M
+8.5%
13AstraZeneca PLCAZN NYSE · HealthcareP/E27.940.5
Mkt Cap
$289.5B
P/E
27.9
P/B
5.8
1M
+19.0%
14Thermo Fisher Scientific IncTMO NYSE · HealthcareP/E36.840.2
Mkt Cap
$257.7B
P/E
36.8
P/B
4.7
1M
+6.4%